LeMaitre Vascular

LeMaitre Vascular (Nasdaq: LMAT) today posted first-quarter results that beat the overall consensus on Wall Street.

Shares in LMAT were up 15.29% to $63.12 apiece at market open.

The company reported profits of $6 million, or 27¢ per share, on sales of $47.1 million for the three months ended March 31, for a sales growth of 19% compared to Q1 2022. Profits did not rise year-over-year.

Adjusted to exclude one-time items, earnings per share were 32¢, 7¢ ahead of The Street, where analysts were looking for sales of $43.54 million.

“Sales surged 22% organically as hospitals staffed up, ASP increased and we increased our rep headcount by 14% to 128. Growth was spread across most products and geographies,” CEO George LeMaitre said in a news release.

Valvulotomes (29%), carotid patches (17%), bovine grafts (22%), allografts (42%) and carotid shunts (18%) drove sales in the first quarter.

For the full-year 2022, LeMaitre Vascular projects sa…

Lemaitre Vascular (NSDQ:LMAT) posted first-quarter results that beat the revenue consensus on Wall Street and missed earnings estimates.

The Burlington, Massachusetts-based vascular device company reported profits of $6 million, or 27¢ per share on sales of $39.6 million for the three months ended March 31, for a bottom-line gain of 1.8% on sales growth of 10.25% compared with Q1 2021.

Get the full story on our sister site, Medical Tubing + Extrusion.

LeMaitre Vascular (NSDQ:LMAT) this week posted fourth-quarter results that beat the overall consensus forecast on Wall Street.

The Burlington, Massachusetts-based company reported profits of $6.2 million, or 28¢ per share, on sales of $39.5 million for the three months ended Dec. 31, 2021, for a bottom-line loss of -12.2% on sales growth of 5.21% compared with Q4 2020.

Get the full story on our sister site, Medical Tubing + Extrusion.

LeMaitre Vascular (NSDQ:LMAT) posted first-quarter results yesterday that beat the consensus on Wall Street.

The company reported profits of $5.9 million, or 28¢ per share, on sales of $35.8 million, for the three months ended March 31, for a bottom-line gain of 86.8% sales growth of 17.45% compared with Q1 2020.

Earnings per share were 28¢∞, 1¢ ahead of The Street, where analysts were looking for sales of $35.2 million.

“Double-digit sales growth and restrained expenses enabled 83% bottom-line growth. And our 22% op. margin enabled us to improve the balance sheet,” CEO George LeMaitre said in a news release.

LeMaitre did not provide a financial outlook for the remainder of the fiscal year.

Shares in LMAT were down -0.2% to $53.86 apiece at a market close yesterday and were at a standstill this morning.